Peripheral Neuropathy Trial, Recruiting NCT06509633 Sponsor: Riphah International University Condition: Peripheral Neuropathy
Back to Peripheral Neuropathy

Peripheral Neuropathy Trial, Recruiting

NCT06509633
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People between 20 and 40 years old
  • People who have received a medical diagnosis of moderate to severe carpal tunnel syndrome (a condition causing pain, numbness, or tingling in the hand and wrist)
  • People who have been experiencing carpal tunnel syndrome symptoms for at least 1 month
  • People with symptoms in one or both hands
  • People who are able to travel to and attend the hospital where the trial is based

Who may not be able to join:

  • People who have difficulty understanding instructions, or who have a condition affecting the brain or spinal cord (such as a stroke or spinal cord injury)
  • People who are currently receiving alternative therapies as part of their treatment
  • People who have previously taken part in a research study or clinical trial
  • People who have previously had surgery on the arm or hand affected by their symptoms

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Saba khan, Riphah International University

Phone: 03324390125

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 February 2024
Est. completion
10 October 2024

Where this trial is recruiting

🇵🇰 Pakistan

Primary endpoints

Numeric pain rate scale (NPRS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov